Startup capital is experiencing a profound paradox in 2026. It is simultaneously more abundant than it has ever been and frustratingly scarce. This glaring contradiction has become increasingly visible throughout the year when analyzing Crunchbase data, and the trend continued unabated through the third quarter.
Market data shows that despite record-shattering venture capital spending in 2026—approaching nearly $680 billion globally through the first three quarters of the year—investors are writing significantly fewer checks to seed and early-stage companies. These are the very businesses that one typically thinks of first when discussing the vibrant, grassroots ecosystem of startups. Instead of distributing capital across a wide, healthy funnel of emerging enterprises, the venture ecosystem is funneling unprecedented amounts of cash into a very select group of mature, heavily capitalized market leaders.
Large Rounds Dominate Funding
One of the best and most striking ways to visualize this growing dichotomy is by looking at how much of the record global venture funding this year went to funding rounds across different financial tiers. Market analysts generally divide these into categories of less than $100 million, $100 million to just under $1 billion, and mega-rounds of $1 billion and more.
The funding surge this year is overwhelmingly concentrated in those largest, top-tier rounds, while the smaller-round market has essentially flatlined, remaining stagnant since 2023. This creates a two-tiered economy where elite companies secure astronomical sums while the broader base of founders struggles to secure basic institutional backing.
The massive surge in billion-dollar-plus rounds during the first and second quarters of the year was, of course, heavily driven by record-setting financings for prominent artificial intelligence pioneers like OpenAI and Anthropic. However, it would be a mistake to view this phenomenon as solely about those two companies. The concentration of capital at the top has broadened: approximately one-third of all global funding in the third quarter went to just 27 companies that successfully raised billion-dollar-plus rounds. This hyper-concentration means that a microscopic fraction of the startup ecosystem is capturing a massive majority of available venture dollars.
Deals Keep Falling Even as Dollars Rise
In North America, historically the largest and most influential startup market in the world, deal counts have trended downward over several consecutive years, even as overall venture investment soared to dizzying heights.
During the third quarter, reported deal counts in North America fell 16% year over year and dropped 14% compared to the previous quarter. This brought the regional deal count down to its lowest quarterly total since 2023. This contraction occurred paradoxically even as North American funding dollars jumped 50% year over year to reach $92 billion in a single quarter. A closer look at the data reveals that this contraction is heavily concentrated in seed and early-stage deals. Conversely, North American late-stage deal counts actually managed to increase year over year, further proving that capital is insulating itself in safer, more mature bets rather than taking risks on new ideas.
The Early-Stage Slump
The Series B stage serves as a particularly stark illustration of this broader dollars-up-but-deals-down trend. Series B typically marks a critical inflection point when startups are maturing beyond their initial experimental phases. At this stage, companies usually show clear signs of commercial growth and product-market traction, but they still retain plenty of upside potential for investors willing to back them.
However, while the total volume of dollars invested in U.S. startups at the Series B stage hit a multiyear high so far this year, the actual deal count is currently on a trajectory to hit a multiyear low. Fewer companies are crossing the Series B threshold, but those that do manage to clear the bar are raising much larger, highly concentrated sums of money.
It is a remarkably similar story among seed and Series A startups as well. Money is rapidly concentrating into larger, more expensive rounds even as the overall deal count dips. Founders attempting to raise their initial institutional capital are finding that while headline numbers look robust, the actual availability of checks for early-stage ventures is tighter than the aggregate statistics might suggest.
Looking Ahead
As the market looks toward the final stretch of the year, all eyes are on Anthropic. As one of the biggest venture-backed private companies in existence, it is slated to go public this month in a landmark potential $2 trillion initial public offering. This massive market debut will offer a prominent, high-stakes test of public investors’ ongoing appetite for the exact type of capital-intensive companies that have been driving the current venture boom.
A strong, enthusiastic public-market reception could significantly reinforce venture investors’ willingness to continue financing enormous artificial intelligence bets well into the future. Conversely, a disappointing debut could put immense valuation pressure on unicorns across the entire tech sector.
Yet, neither outcome guarantees that this abundance of capital will finally begin to trickle down to reach a wider, more diverse pool of early-stage startups. The real measure of a genuine, broad-based startup recovery that industry watchers will be monitoring closely is whether overall deal counts finally start to rise alongside the headline-grabbing funding dollars.
